Fig. 7

Differences in Clinical Characteristics and Biological Factors Between AML Patients in the high- and low-risk scoring groups in the TCGA Database. (A, B) Differences in somatic mutation frequency between the high-risk (A) and low-risk(B) scoring groups. (C-H) Differences in risk scores between clinicopathological factors. The interquartile ranges of the values are represented by the upper and lower ends of the boxes. The median values are represented by the lines in the boxes. The statistical P-values are represented by the asterisks (**P < 0.01; ns, no significance).